METROPOLITAN LIFE INSURANCE CO/NY - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$21,750
-11.7%
1,2110.0%0.00%0.0%
Q2 2023$24,632
-6.5%
1,2110.0%0.00%0.0%
Q1 2023$26,351
-29.8%
1,2110.0%0.00%
-50.0%
Q4 2022$37,529
+21.5%
1,2110.0%0.00%0.0%
Q3 2022$30,893
+25.7%
1,2110.0%0.00%
+100.0%
Q2 2022$24,583
-17.9%
1,2110.0%0.00%0.0%
Q1 2022$29,960
-84.7%
1,211
-78.5%
0.00%
-66.7%
Q4 2021$195,643
+28.1%
5,6300.0%0.00%
+50.0%
Q3 2021$152,686
-26.4%
5,630
-29.6%
0.00%
-33.3%
Q2 2021$207,362
+29.1%
7,997
+7.3%
0.00%
+50.0%
Q1 2021$160,569
-8.4%
7,451
-8.6%
0.00%
-33.3%
Q4 2020$175,311
+45.8%
8,1540.0%0.00%
+50.0%
Q3 2020$120,272
-34.0%
8,1540.0%0.00%
-33.3%
Q2 2020$182,160
+58.1%
8,1540.0%0.00%
+50.0%
Q1 2020$115,216
-13.0%
8,1540.0%0.00%0.0%
Q4 2019$132,503
-53.6%
8,1540.0%0.00%
-60.0%
Q3 2019$285,308
-29.2%
8,154
+14.2%
0.01%
-28.6%
Q2 2019$402,951
-20.6%
7,142
+2.8%
0.01%
-22.2%
Q1 2019$507,332
+14.5%
6,9450.0%0.01%0.0%
Q4 2018$443,022
-23.3%
6,945
+19.9%
0.01%
-10.0%
Q3 2018$577,768
-99.9%
5,7910.0%0.01%
+42.9%
Q2 2018$411,392,000
-31.7%
5,7910.0%0.01%
-22.2%
Q1 2018$602,727,000
+105641.6%
5,791
+2.4%
0.01%
+12.5%
Q4 2017$570,000
+88.1%
5,657
-34.7%
0.01%
+300.0%
Q3 2017$303,0008,6600.00%
Other shareholders
ANAPTYSBIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders